Eric is Chief Medical Officer of RareCyte, directing scientific and medical applications of its rare cell detection technology. Before joining RareCyte he was Medical Director for Companion Diagnostics at Ventana Medical Systems/Roche. His pharmaceutical experience at Hoffmann-La Roche and at Parke-Davis/Pfizer encompassed discovery research through full clinical development positions with a focus on translational medicine. He was Chief Scientific Officer at Transgenomic and directed clinical genomics programs at Gene Logic. He received his anatomic pathology training at the University of Michigan and was a hematopathology/immunology fellow at the National Cancer Institute. He is an associate member of the BioInterfaces Institute at the University of Michigan.
Next-Generation Liquid Biopsy
Tuesday, 27 September 2016 at 15:00
Add to Calendar ▼2016-09-27 15:00:002016-09-27 16:00:00Europe/LondonNext-Generation Liquid BiopsyNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
To fully exploit the non-invasive potential of liquid biopsy, rare cells must be collected and identified without size or protein expression bias and be available for assessment of pertinent phenotypic and molecular characteristics. This presentation will describe pre-clinical and clinical applications of the recently commercialized AccuCyte-CyteFinder system, an integrated platform technology for collection, up to six-parameter visualization, and single-cell retrieval for genomic analysis of circulating tumor and fetal cells.
Add to Calendar ▼2016-09-26 00:00:002016-09-28 00:00:00Europe/LondonNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016NGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2016-09-27 15:00:002016-09-27 16:00:00Europe/LondonNext-Generation Liquid BiopsyNGS, SCA, SMA and Mass Spec: Research to Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
